Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 4,874 | 4,019 | 2,243 | 902 | 988 |
| Cost of Goods | 1,064 | -261 | 418 | 295 | 359 |
| Gross Profit | 3,810 | 4,280 | 1,825 | 607 | 629 |
| Operating Expenses | 27,200 | 21,821 | 14,492 | 45,614 | 23,002 |
| Operating Income | -23,326 | -17,802 | -12,249 | -44,712 | -22,014 |
| Interest Expense | 1,609 | 794 | 236 | 273 | 307 |
| Other Income | -564 | -28 | 28,033 | 515 | 5,034 |
| Pre-tax Income | -25,499 | -18,624 | 15,548 | -44,470 | -17,287 |
| Income Tax | -1,696 | -701 | -195 | N/A | N/A |
| Net Income Continuous | -23,803 | -17,923 | 15,743 | -44,470 | -17,287 |
| Minority Interests | -739 | -66 | -147 | -1,164 | -1,637 |
| Net Income | $-23,064 | $-17,857 | $15,890 | $-43,306 | $-15,650 |
| EPS Basic Total Ops | -0.45 | -0.11 | 0.24 | -0.93 | -0.41 |
| EPS Basic Continuous Ops | -0.47 | -0.10 | 0.24 | -0.96 | -0.46 |
| EPS Diluted Total Ops | -0.45 | -0.11 | 0.24 | -0.93 | -0.41 |
| EPS Diluted Continuous Ops | -0.47 | -0.09 | 0.24 | -0.96 | -0.46 |
| EBITDA(a) | $-21,706 | $-16,140 | $-12,127 | $-44,156 | $-21,469 |